뉴저지의 제2형 당뇨병 임상 시험
제2형 당뇨병 관련 연구 15개가 뉴저지 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴저지의 도시
공식 연구 텍스트(영어)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Advanced Heart Care, LLC, Bridgewater
- NJ Heart LLC, Linden
- Cardio Metabolic Institute, Somerset
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
- Virtua Health, Inc., Marlton
- Rutgers State University, New Brunswick
- 외 2개
피험자 모집 중건강한 지원자 환영
55세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Somerset
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Hypertension & Nephrology Association, Eatontown
- IMA Clinical Research Warren, Warren Township
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Eatontown
- Research Site, Somerset
- Research Site, Warren Township
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Jersey City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Hassman Research Institute - Berlin - CenExel - PPDS, Berlin
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Clinical Research of Philadelphia, Pennington
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06897475A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Premier Research, Trenton
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Premier Research, Trenton
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07684144Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
- Rutgers Health Family Medicine at Monument Square, New Brunswick
- University Medical Group General Internal Medicine, New Brunswick
피험자 모집 중
18세 ~ 90세 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT06814184Exercise and Intranasal Insulin in Type 2 Diabetes
- Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick
- Institute for Food, Nutrition, and Health, New Brunswick
- Rutgers University Loree Gymnasium, New Brunswick
- 외 1개
피험자 모집 중2/3상
55세 ~ 80세 · 모든 성별 · 2026. 6. 30. 업데이트됨 · NCT07675499Extracellular Vesicles, Insulin Action, and Exercise
- Institute for Food, Nutrition, and Health, New Brunswick
- Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick
- Rutgers University Loree Gymnasium, New Brunswick
피험자 모집 중건강한 지원자 환영
30세 ~ 80세 · 모든 성별 · 2026. 1. 23. 업데이트됨 · NCT06546085CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
- Jefferson Health New Jersey, Sewell
피험자 모집 중
18세 이상 · 여성 · 2025. 10. 14. 업데이트됨 · NCT07184775Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
- One Robert Wood Johnson Place, New Brunswick
- One Robert Wood Johnson Place, New Brunswick
피험자 모집 중
18세 이상 · 모든 성별 · 2024. 12. 18. 업데이트됨 · NCT06663813ClinicalTrials.gov 출처, 2026. 10. 4. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.